The Group has two standing Board Committees: an Audit Committee and a Remuneration Committee, the membership of which is made up solely of the Independent Non-Executive Directors.

The functions of a Nominations Committee are undertaken by the Board as a whole. Where necessary and appropriate, a nominations sub-committee is appointed temporarily to fulfil specific tasks. Given the size of the Group, and the size and composition of its Board, the Directors believe it is both practical and beneficial for matters of Board composition and recruitment, Board performance evaluation, Executive and Non-Executive succession planning, and training and development to be undertaken by the Board as a whole. All such matters are regularly scheduled on the Board’s agenda and are discussed thoroughly and robustly, incorporating the detailed perspectives and experience of all Directors.

Audit Committee

The Audit Committee (the "Committee") comprises:

  • Jon Kempster (Chair of the Committee), Independent Non-Executive Director 
  • Dr Alison Vincent, Independent Non-Executive Director
  • Andrew Lockwood, Independent Non-Executive Director

All of the Committee members have no personal or financial interests, other than as shareholders, in the matters considered by the Committee.

The Committee is responsible for ensuring that the Company maintains a strong control environment. It provides effective governance over the Group’s financial reporting, including oversight and review of the systems of internal control and risk management and the performance of internal and external audit functions.

The Committee’s formal terms of reference, which are reviewed and approved annually, set out its duties delegated by the Board. These can be accessed here: Audit Committee Terms of Reference.

Neither the Executive Directors or the Chair attends meetings of the Committee other than by invitation. The Committee invites the external auditor to attend certain meetings.

The Committee is authorised by the Board to obtain external professional advice at the Group’s expense in order to perform its duties.

Summary of the Committee’s responsibilities:

  • Reviewing the half-year and annual financial statements and formal announcements relating to financial performance and advising the Board on whether they are fair, balanced and understandable;
  • Reviewing the external auditors’ independence and considering the nature, scope, and results of the audit and reviewing the policy on any non-audit services that are provided by the external auditors and making recommendations to the Board on their appointment and remuneration;
  • Reviewing compliance with legal requirements, accounting standards and the AIM Rules;
  • Ensuring that effective systems of internal financial and non-financial controls (including for the management of risk and whistleblowing) are maintained;
  • Reviewing and agreeing the scope and work of the Group’s internal audit activities and considering findings of internal investigations and management’s response to these, and
  • Reviewing the Committee’s performance, constitution and terms of reference to ensure it operates effectively and recommending any changes to the Board for approval.

Key activities and matters dealt with by the Committee in 2025

February

  • Review of Group risk registers and risk management
  • Review of final results with the external auditor
  • The suitability of the Group’s accounting policies and practices
  • The adoption of the outcomes of the assessments of goodwill impairment and going concern and recommending to the Board that it is appropriate to adopt those assumptions
  • Approval of the Committee Report

July

  • Review of Group risk registers and risk management
  • External auditor assessment
  • Tender of external audit
  • Review of interim results
  • Review of the Whistleblowing, Anti-Bribery and Corruption and Non-Audit services policies
  • Review of the Committee’s terms of reference

October

  • Review of Group risk registers and risk management
  • Review and approval of the external auditor’s plan for 2025, which detailed the proposed audit scope and risk and assessment

The Group’s Remuneration Committee (the “Committee”) comprises:

  • Andrew Lockwood (Chair of the Committee), Independent Non-Executive Director
  • Dr Alison Vincent, Independent Non-Executive Director
  • Jon Kempster, Independent Non-Executive Director

The Committee members have no personal or financial interests, other than as shareholders, in the matters considered by the Committee.

The Committee operates within the remit delegated by the Board, which is set out in formal terms of reference. The remuneration of Non-Executive Directors is a matter for the Chair and the Executive Directors. No Director or manager is involved in any decision regarding their own remuneration. A copy of the terms of reference can be accessed here: Remuneration Committee Terms of Reference.

Neither the Executive Directors or the Chair attend other than by invitation of the Committee and are not present at any discussion of their own remuneration.

The Committee Chair reports formally to the Board on the Committee’s proceedings after each meeting; ensures that an annual report of the Group’s remuneration policy and practices is published in the Group’s Annual Report and Accounts; and ensures each year that the Remuneration Committee Report, which contains the Directors’ remuneration, is put to shareholders for approval at the AGM.

The Committee is authorised by the Board to seek any information it requires from any employee of the Group in order to perform its duties and to obtain external professional advice at the Group’s expense

Summary of the Committee’s responsibilities:

  • Making recommendations to the Board for approval of overall Group remuneration policies, and the specific remuneration each year for all Directors and the senior management team, including bonuses, incentive payments and share options and awards;
  • Ensuring Executive Directors and the senior management team are provided with appropriate incentives to encourage enhanced performance in a fair and reasonable manner;
  • Reviewing the design of share incentive plans for approval by the Board and determining the policy on annual awards to Executive Directors and senior management and reviewing progress made against performance targets and agreeing incentive awards;
  • Reviewing the Committee’s performance, constitution and terms of reference to ensure it operates effectively and to recommend any changes to the Board for approval.

Key activities and matters dealt with by the Committee in 2025

February

  • Recruitment and remuneration of new Chief Financial Officer
  • Approval of the Committee Report
  • Approval and payment of Chief Executive Officer 2024 bonus
  • Approval of the vesting of 2022
  • PSP awards
  • Discussion of 2025 share awards

May

  • Vesting of 2022 PSP awards
  • Discussion of 2025 share awards

July

  • Review of the Share Dealing Policy and code
  • Review of Committee’s terms of reference
  • Update on Mr Webb’s vested awards
  • Discussion of 2025 share awards